Center Chronic Patient Adherence Behavior Analysis and Intervention Strategies Based on Prospect Theory
DOI:
https://doi.org/10.54097/2yh4qb24Keywords:
Patient Adherence; Prospect Theory; Chronic Disease Management; Behavioral Interventions; Decision-Making Biases.Abstract
Chronic diseases pose a global public health challenge; however, the primary obstacle to effective management is low patient treatment adherence. The traditional rational decision-making model is difficult to explain the internal motivations of adherence behavior fully. This study introduces the prospect theory of behavioral economics, aiming to deeply analyze the psychological mechanism of adherence decision-making in patients with chronic diseases and propose targeted intervention strategies. The study selected stroke prevention in patients with hypertension, diabetes, and schizophrenia as typical cases. Based on the latest international research results and real-world data, it revealed the universality and complexity of adherence issues. Analysis shows that the decision-making behavior of patients is significantly influenced by reference point dependence, loss aversion, and probability weight distortion. There are not only positive effects, such as using loss aversion for effective health warnings, but also deep-seated problems, such as excessive optimism, present bias, emotional avoidance, and information bias, that are exposed. To directly counter these biases, this paper proposes four strategies: integrating an information framework, applying a commitment mechanism, adjusting reference points, and designing immediate incentives, providing innovative solutions from the perspective of behavioral economics for improving the compliance of chronic disease patients worldwide. This research demonstrates the critical value of applying behavioral economics to health behavior change compared with traditional and rationalistic approaches.
Downloads
References
[1] World Health Organization. Global status report on noncommunicable diseases 2023. Geneva: WHO, 2024.
[2] Cutler, Rachelle Louise, et al. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open, 2018, 8(1), e016982.
[3] Wang Ying & Liu Lian. How does the reference point influence self-management behaviors in patients with type 2 diabetes? A qualitative study. Psychology, Health & Medicine, 2019, 24(6), 729-737.
[4] Zhang Min, Wang Jiu & Wang Cui. Applying prospect theory to understand the medication adherence of patients with chronic pain. Journal of Behavioral Medicine, 2020, 43(5), 784-794.
[5] Li Xue & Chen Yun. The effect of message framing on medication adherence among patients with hypertension: A randomized controlled trial. Patient Education and Counseling, 2021, 104(5), 1074-1081.
[6] Columbia University Irving Medical Center. Hypertension management in primary care: Annual report 2023. New York: CUIMC Press.
[7] Ontario Health Study. Medication adherence in patients with severe mental illness: A population-based cohort study. Toronto: OHS Publications, 2022.
[8] Kim, Nam Hoon, et al. First-year medication adherence and long-term outcomes in type 2 diabetes: A nationwide cohort study. Diabetes Care, 2025, 48(1), 123-130.
[9] Juyeong Lee & Park Haechan. The paradox of complex regimens: Better adherence in combination therapy. Patient Preference and Adherence, 2024, 18, 234-245.
[10] ENGAGE-HTN Research Group. A randomized factorial trial of behaviorally informed strategies to improve adherence to antihypertensive medications. Circulation, 2023, 147(10), 789-801.
[11] Tom, Sabrina M., et al. The neural basis of loss aversion in decision-making under risk. Science, 2007, 315(5811), 515-518.
[12] Sharot Tali, et al. How dopamine enhances an optimism bias in humans. Current Biology, 2012, 21(17), 1476-1481.
[13] De Martino, Benedetto, et al. Frames, biases, and rational decision-making in the human brain. Science, 2006, 313(5787), 684-687.
[14] Volpp Kevin G., et al. Effect of electronic reminders, financial incentives, and social support on outcomes after myocardial infarction: A randomized clinical trial. JAMA, 2017, 318(12), 1145-1153.
[15] Asch David A., et al. Effect of financial incentives to physicians, patients, or both on lipid levels: A randomized clinical trial. JAMA, 2015, 314(18), 1926-1935.
[16] Müller Sebastian, et al. Social comparison-based mobile health intervention for patients with type 2 diabetes: A randomized controlled trial. The Lancet Digital Health, 2022, 4(6), e412-e421.
[17] Michie Susan, Maartje M. Van Stralen, and Robert West. The behavior change wheel: A new method for characterizing and designing behavior change interventions. Implementation Science, 2011, 8(1), 1-12.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

